Holland named CEO of Isomark

WARF startup focuses on development of portable device to identify onset of serious infectionsMADISON, Wis. – Neil Holland has been named chief executive officer of Isomark, a startup company based on technology developed at the University of Wisconsin–Madison to identify the early onset of bacterial infections, including serious hospital-related infections such as sepsis. Holland has more than 25 years of medical device industry management experience and previously served as vice president of global device research and development with Hospira, a $4 billion global leader in injectable